David Hermanson

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Ye Li, David Hermanson, Branden S. Moriarity et al. · Cell stem cell · 2018 · 959 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +7

Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy

David A. Knorr, Zhenya Ni, David Hermanson et al. · Stem Cells Translational Medicine · 2013 · 407 citations · Full text

Cancer Therapy, Cell Therapy, Adult Stem Cell +19

Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer

David Hermanson, Laura E. Bendzick, Lee J. Pribyl et al. · Stem Cells · 2015 · 236 citations · Full text

Cell Therapy, Immunology, Nk Cells +17

Structure−Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4<i>H</i>-chromene-3-carboxylate (sHA 14-1) and Its Analogues

Sonia G. Das, Jignesh Doshi, Defeng Tian et al. · Journal of Medicinal Chemistry · 2009 · 74 citations · Full text

Structure–Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4<i>H</i>-chromene-3-carboxylate (CXL017) and Its Analogues

Sonia G. Das, Balasubramanian Srinivasan, David Hermanson et al. · Journal of Medicinal Chemistry · 2011 · 58 citations

Structure–activity Relationship, Chemoprevention Strategy, Multidrug Resistance +24